BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19996066)

  • 1. Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.
    Bavry AA; Anderson RD; Gong Y; Denardo SJ; Cooper-Dehoff RM; Handberg EM; Pepine CJ
    Hypertension; 2010 Jan; 55(1):48-53. PubMed ID: 19996066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
    Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
    J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hypertension in peripheral arterial disease.
    Lane DA; Lip GY
    Cochrane Database Syst Rev; 2013 Dec; (12):CD003075. PubMed ID: 24307487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
    Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
    J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
    Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
    J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
    Cooper-DeHoff RM; Gong Y; Handberg EM; Bavry AA; Denardo SJ; Bakris GL; Pepine CJ
    JAMA; 2010 Jul; 304(1):61-8. PubMed ID: 20606150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).
    Zineh I; Cooper-Dehoff RM; Wessel TR; Arant CB; Sleight P; Geiser EA; Pepine CJ
    Clin Cardiol; 2005 Jul; 28(7):321-8. PubMed ID: 16075824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
    Bakris GL; Gaxiola E; Messerli FH; Mancia G; Erdine S; Cooper-DeHoff R; Pepine CJ;
    Hypertension; 2004 Nov; 44(5):637-42. PubMed ID: 15381674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
    Bangalore S; Gong Y; Cooper-DeHoff RM; Pepine CJ; Messerli FH
    J Am Coll Cardiol; 2014 Aug; 64(8):784-93. PubMed ID: 25145522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
    Messerli FH; Mancia G; Conti CR; Hewkin AC; Kupfer S; Champion A; Kolloch R; Benetos A; Pepine CJ
    Ann Intern Med; 2006 Jun; 144(12):884-93. PubMed ID: 16785477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).
    Winchester DE; Cooper-Dehoff RM; Gong Y; Handberg EM; Pepine CJ;
    Clin Cardiol; 2013 Aug; 36(8):442-7. PubMed ID: 23720247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.
    Bavry AA; Khaliq A; Gong Y; Handberg EM; Cooper-Dehoff RM; Pepine CJ
    Am J Med; 2011 Jul; 124(7):614-20. PubMed ID: 21596367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
    Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
    Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
    Dasa O; Smith SM; Howard G; Cooper-DeHoff RM; Gong Y; Handberg E; Pepine CJ
    JAMA Netw Open; 2021 Apr; 4(4):e218418. PubMed ID: 33914047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerotic risk factor control in patients with peripheral arterial disease.
    Rehring TF; Sandhoff BG; Stolcpart RS; Merenich JA; Hollis HW
    J Vasc Surg; 2005 May; 41(5):816-22. PubMed ID: 15886666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Blood Pressure Measurements With Peripheral Artery Disease Events.
    Itoga NK; Tawfik DS; Lee CK; Maruyama S; Leeper NJ; Chang TI
    Circulation; 2018 Oct; 138(17):1805-1814. PubMed ID: 29930023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
    Holzgreve H; Nakov R; Beck K; Janka HU
    Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
    Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
    Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.